Error: Could not add to watchlist. X

Immuron Ltd

+ Watchlist
IMROY:US
OTC US
USD
Volume
0
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (AUD) (TTM)
-
Market Cap (USD)
-
Shares Outstanding (m)
3.748
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Immuron Ltd. is a biotechnology company. The Company researches oral immunotherapeutic products to treat gastrointestinal, infectious, and immune- mediated diseases.
ADDRESS
Level 1 39 Leveson Street
North Melbourne, VIC 3051
Australia
PHONE
61-3-9018-4880
  • Peter Anastasiou
    Vice Chairman
  • Thomas Liquard
    Chief Executive Officer
  • Peter Vaughan
    Co-CFO/Joint Secretary
  • Phillip Hains
    Co-CFO/Joint Secretary
  • Grant Rawlin
    Chief Scientific Officer
Show More